Clinical Trials Directory

Trials / Completed

CompletedNCT05858320

The Impact of an Adaptive Patient-centered Web Application on Medication Optimization in HFrEF Patients

The Impact of an Adaptive Patient-centered Web Application on Medication Optimization in HFrEF Patients (SmartHF)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
225 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The SmartHF study is a 12-week prospective randomized controlled multicenter clinical trial. This study will investigate the efficacy of an adaptive web application to facilitate guideline-directed medical therapy (GDMT) optimization in HFrEF patients. Eligible participants will be randomized to the web application intervention or control in a 1:1 manner, stratified by site. The intervention is an adaptive medication optimization web application that extracts and analyzes the EHR data with a computable medication optimization algorithm. The algorithm provides a medication quality score and outputs medication optimization recommendations written in a patient -friendly manner.

Detailed description

The investigators have developed an adaptive medication optimization web application, named SmartHF, that provides patients with tailored information about potential HFrEF GDMT optimization. SmartHF guides patients to share the GDMT optimization recommendations with their provider during a clinic visit. Participants will be randomized to receive the web application intervention or control up to 30 days before a clinic visit in a 1:1 manner and followed for 12 weeks after the clinic visit. This trial will determine the efficacy of SmartHF in prescribing GDMT in HFrEF patients compared to controls.

Conditions

Interventions

TypeNameDescription
OTHERSmartHF applicationAdaptive medication recommendations that can be shared with the participants HF provider.

Timeline

Start date
2023-07-21
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2023-05-15
Last updated
2026-01-16

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05858320. Inclusion in this directory is not an endorsement.